Polymorphism in anhydrous theophylline - Implications on the dissolution rate of theophylline tablets

Journal of Pharmaceutical Sciences

Volumn 86, Issue 11, 1997, Pages 1256-1263

  Phadnis, Neelima V ^a   Suryanarayanan, Raj ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THEOPHYLLINE;

ARTICLE; ASTHMA; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DNA POLYMORPHISM; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG SOLUBILITY; FREEZE DRYING; NONHUMAN; THERMOGRAVIMETRY;

EID: 0030724408     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9701418     Document Type: Article

References (26)

1. Saleki-Gerhardt, A.; Ahlneck, C.; Zografi, G. Assessment of disorder in crystalline solids. Int. J. Pharm. 1994, 101, 237-247.
2. Puttipipatkhachorn, S.; Yonemochi, E.; Oguchi, T.; Yamamoto, K.; Nakai Y. Effect of grinding on dehydration of crystal water of theophylline. Chem. Pharm. Bull. 1990, 38, 2233-2236.
3. Iyer, N. Effect of storage under high relative humidity on the properties of carbamazepine tablets. M.S. Thesis, University of Minnesota, 1994.
4. Han, J.; Suryanarayanan, R. Influence of water vapor pressure on the mechanism of dehydration of carbamazepine dihydrate. Pharm. Res. 1996, 13S, 356.
5. Herman, J.; Remon, J. P.; Visavarungroj, N.; Schwartz, J. B.; Klinger, G. H. Formation of theophylline monohydrate during the pelletisation of microcrystalline cellulose-anhydrous theophylline blends. Int. J. Pharm. 1988, 42, 15-18.
6. Shefter, E.; Higuchi, T. Dissolution behavior of crystalline solvated and nonsolvated forms of some pharmaceuticals. J. Pharm. Sci. 1962, 52, 781-791.
7. Shefter, E.; Fung, H. L.; Mok, O. Dehydration of crystalline theophylline monohydrate and ampicillin trihydrate. J. Pharm. Sci. 1973, 62, 791-794.
8. Otsuka, M.; Kaneniwa, N. The dehydration kinetics of theophylline monohydrate powder and tablet. Chem. Pharm. Bull. 1988, 36, 4914-4920.
9. Suzuki, E.; Shimomura, K.; Sekiguchi, K. Thermochemical study of theophylline and its hydrate. Chem. Pharm. Bull. 1989, 37, 493-497.
10. Agbada, C. O.; York, P. Dehydration of theophylline monohydrate powder - effects of particle size and sample weight. Int. J. Pharm. 1994, 106, 33-40.
11. Duddu, S. P.; Das, N. G.; Kelly, T. P.; Sokoloski, T. D. Microcalorimetric investigation of phase transitions: I. Is water desorption from theophylline·HOH a single-step process. Int. J. Pharm. 1995, 114, 247-256.
12. Sutor, D. J. The structures of the pyrimidines and purines. VI. The structure of theophylline. Acta Crystallogr. 1958, 11, 83-87.
13. Naqvi, A. A.; Bhattacharya, G. C. Crystal data for anhydrous theophylline. J. Appl. Crystallogr. 1981, 14, 464.
14. de Smidt, J. H.; Fokkens, J. G.; Grijseels, H.; Crommelin, D. J. A. Dissolution of theophylline monohydrate and anhydrous theophylline in buffer solutions. J. Pharm. Sci. 1986, 75, 497-501.
15. Wadke, D. A.; Reier, G. E. Use of intrinsic dissolution rates to determine thermodynamic parameters associated with phase transitions. J. Pharm. Sci. 1972, 61, 868-871.
16. Pearson, J. T.; Varney, G. Crystal growth studies involving phase transitions in aqueous drug suspensions. J. Pharm. Pharmacol. 1969, 21S, 60-69.
17. Bogardus, J. B. Crystalline anhydrous-hydrate phase changes of caffeine and theophylline in solvent-water mixtures. J. Pharm. Sci. 1983, 72, 837-838.
18. Rodriguez-Hornedo, N.; Wu, H. Crystal growth kinetics of theophylline monohydrate. Pharm. Res. 1991, 8, 643-648.
19. Phadnis, N. V.; Ward, G. H.; Suryanarayanan, R. Identification of a new polymorph of anhydrous theophylline. Midwest AAPS Meeting, Chicago, IL, 1995.
20. Phadnis, N. V.; Suryanarayanan, R. Use of high temperature powder X-ray diffractometry for the identification of a new polymorph of anhydrous theophylline. 44th Annual Denver X-ray Conference, Colorado Springs, CO, 1995.
21. The United States Pharmacopeia, XXIII revision; United States Pharmacopeial Convention: Rockville, MD, 1994; pp 1523, 1792.
22. Powder Diffraction File: Set 26, Organic Databook (Editor-in-Chief, W. F. McClune); International Centre for Diffraction Data, Swarthmore, PA, 1985; p 299.
23. Powder Diffraction File: Set 27, Organic Databook (Editor-in-Chief, W. F. McClune); International Centre for Diffraction Data, Swarthmore, PA, 1986; p 159.
24. Byrn, S.; Pfeiffer, R.; Ganey, M.; Hoiberg, C.; Poochikian, G. Pharmaceutical solids: a strategic approach to regulatory considerations. Pharm. Res. 1995, 12, 945-954.
25. Physicians' Desk Reference, 51st ed.; Medical Economics: Oradell, NJ, 1997; pp 319, 330, 1011, 1557, 2157, 2748, 2753.
26. Ketolainen, J.; Poso, A.; Vitasaari, V.; Gynther, J.; Pirttimaki, J.; Laine, E.; Paronen, P. Changes in solid-state structure of cyclophosphamide monohydrate induced by mechanical treatment and storage. Pharm. Res. 1995, 12, 299-304.